Skip to content

Clinical trials

Phase 1 Hepatitis B trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 1 Country / region: United States Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20123
20131
20142
20153
20181
20194
20203
20212
20231
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences4
GlaxoSmithKline4
Dynavax Technologies Corporation3
Assembly Biosciences2
Enanta Pharmaceuticals, Inc2
Albert B. Sabin Vaccine Institute1
Bader, Ted, M.D.1
Baylor Research Institute1
GigaGen, Inc.1
Hepion Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B28
Hepatitis B, Chronic5
Hepatitis4
Hepatitis C3
Communicable Diseases2
Fibrosis2
Kidney Failure, Chronic2
Liver Diseases2
Acquired Immunodeficiency Syndrome1
Angioedemas, Hereditary1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.